Vanguard Global Advisers »

Cellectar Biosciences shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4k 563 2.54

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Cellectar Biosciences

Bleichroeder
Vanguard Group
Vanguard Capital Management
Geode Capital Management
Sequoia Financial Advisors
Vanguard Fiduciary Trust
Warberg Asset Management
XTX Topco
Susquehanna International
Riverview Capital Advisers
UBS Group
BlackRock
Tower Research Capital
Vanguard Global Advisers
Morgan Stanley

View all funds holding Cellectar Biosciences